INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
FM
Futch Aaron MichaelEVP, GC and Secretary
RDWRedwire Corp
Open-market purchase
BUY$1.3
0 sh
Nov 14, 2025Nov 14, 2025
Page 531 of 550
← PrevNext →
traded Nov 14, 2025
+0d
SEC Form 4

Evidence

39
GC
Gassert ChadSVP - CORP. DEV. & STRATEGY
ANIPANI PHARMACEUTICALS INC
Open-market sale
SELL$1.30M
14.6K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

38
HJ
Hecker Rick JosephSVP & GENERAL COUNSEL
DGICADONEGAL GROUP INC
Open-market sale
SELL$18K
900 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

38
CF
Cash Paul FGeneral Counsel & Corp. Secy.
WHWYNDHAM HOTELS & RESORTS, INC.
Open-market sale
SELL$2.61M
36.4K sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

38
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
700 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

37
BJ
Battershell Carol JaneDirector
GEVOGevo, Inc.
Open-market sale
SELL$153K
75.6K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

37
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$699K
7,710 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

36
EI
Eskenazi IleneDirector
AKAA.K.A. BRANDS HOLDING CORP.
Open-market sale
SELL$157K
12.2K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

36
BM
Brehm Kyle M.Director
SEZLSezzle Inc.
Open-market purchase
BUY$70K
1,217 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$56K
154 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$89K
251 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$175K
500 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
LG
Lepore Dawn GDirector
LDIloanDepot, Inc.
Open-market sale
SELL$89K
30.6K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

33
HS
HSU Hsenghung SamDirector
FASTFASTENAL CO
Open-market purchase
BUY$50K
1,000 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

33
BJ
Baack Jerry J.Director, CEO
BWBBridgewater Bancshares Inc
Open-market sale
SELL$307K
18.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

32
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$2.95M
9,196 sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

32
DB
Dageville BenoitDirector, Founder and Chief Architect
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$6.61M
25.0K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

31
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$43K
120 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

31
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$36K
100 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

31
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale
SELL$267K
30.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$116K
332 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$232K
664 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
BJ
Baack Jerry J.Director, CEO
BWBBridgewater Bancshares Inc
Open-market sale
SELL$119K
6,993 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

29
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$496K
1,532 sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

29
SS
Smith R SharonExec VP & Group COO
AMBCOCTAVE SPECIALTY GROUP INC
Open-market purchase
BUY$205
20 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

29
LN
Look NicholasGeneral Counsel and Secretary
SMASmartStop Self Storage REIT, Inc.
Open-market sale
SELL$15K
458 sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

28
DR
Damon RyanChief Legal Officer
CRTOCriteo S.A.
Open-market sale
SELL$143K
6,444 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

28
RK
Radigan KevinCHIEF ACCOUNTING OFFICER
UIUbiquiti Inc.
Open-market sale
SELL$202K
350 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

28
Sylebra Capital LlcSee Footnotes
PIIMPINJ INC
Open-market sale
SELL$590K
3,772 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

28
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$3.60M
11.3K sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

28
MA
Munoz AdamPresident and COO
PUMPProPetro Holding Corp.
Open-market sale
SELL$175K
17.2K sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

28
TM
Tenner MandyEVP, Chief Legal Officer
AMALAmalgamated Financial Corp.
Open-market sale
SELL$95K
3,425 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

26
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$200K
616 sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

26
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.58M
42.8K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

25
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$592K
1,839 sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

24
LD
Lampert DarrenDirector, CEO
GRWGGrowGeneration Corp.
Open-market sale
SELL$122K
70.3K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

24
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$301K
3,072 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

24
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$815K
19.9K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

23
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$701K
18.6K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

23
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$546K
7,333 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence